Individuals Stopping Slimming Medications Gain Back Pounds Four Times Faster Compared to Dieters

Fresh analysis suggests that patients who come off blockbuster GLP-1 drugs like Mounjaro or Wegovy tend to recover shed pounds far faster than those who halt traditional diet and exercise regimens.

Published data in a prominent health publication shows that while obese individuals can lose a large proportion of their body weight while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month once they quit.

"People purchasing these drugs need to be aware of the danger of fast weight regain when the therapy concludes," cautioned researcher Dr. Susan Jebb.

That rate of regain means a reversion to pre-treatment mass in about 18 months.

Weighing Treatments

The study, which looked at dozens of trials involving over 9,000 of participants, compared the outcomes of GLP-1 agonists with older methods.

The team emphasize that individuals who lose weight through diet and exercise typically experience a less rapid weight regain—around 0.1 kg a month—after stopping.

Explaining the Fast Rebound

Nutrition scientists believe the mode of action of the drugs accounts for the heightened rebound.

These medications copy a body's own chemical called GLP-1, which helps regulate hunger.

"Sustained high doses of the hormone concentrations far above than the body's typical production might result in the system to produce less of its endogenous hormone, and may also lessen sensitivity to its actions," said Dr. Adam Collins, a nutrition specialist.

"Stopping of this medication leads to appetite is uncontrolled, making overeating a significant risk."

A Lifelong Issue?

Health authorities suggest the injections for individuals with obesity-related medical conditions, accompanied by prescribed lifestyle changes.

Many experts say that, due to the likelihood of weight regain, the therapy is often long-term.

This opinion is supported by drug manufacturers, who note that the findings "emphasize the chronic nature of excess weight," comparing it to managing conditions like diabetes.

User Accounts

People who have stopped the jabs explain a intense resurgence of hunger.

"It was like something flipping and you're instantly starving," recalled an individual.

This challenge is compounded if patients have not established lasting lifestyle or habit changes during treatment.

Growing Adoption

Figures indicate that a significant number of adults in the UK have tried these injections in the last 12 months, with interest remaining high.

• Use is more common among women than males.
• The middle-aged demographic shows the greatest level of interest.
• Many obtain the medications through private healthcare rather than the NHS.

Ultimately, researchers caution that while GLP-1 drugs are effective agents for weight loss, they are not a magic solution and long-term success relies on combined lifestyle management.